Phio Pharmaceuticals PHIO Stock
Phio Pharmaceuticals Price Chart
Phio Pharmaceuticals PHIO Financial and Trading Overview
| Phio Pharmaceuticals stock price | 1.04 USD |
| Previous Close | 1.03 USD |
| Open | 1.04 USD |
| Bid | 0.77 USD x 200 |
| Ask | 1.35 USD x 200 |
| Day's Range | 1.04 - 1.08 USD |
| 52 Week Range | 0.81 - 4.19 USD |
| Volume | 236.26K USD |
| Avg. Volume | 166.41K USD |
| Market Cap | 12.2M USD |
| Beta (5Y Monthly) | 0.811 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.38 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14 USD |
PHIO Valuation Measures
| Enterprise Value | -4832887 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.2209301 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.7410021 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.42 |
Trading Information
Phio Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.811 |
| 52-Week Change | -52.48% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 4.19 USD |
| 52 Week Low | 0.81 USD |
| 50-Day Moving Average | 1.14 USD |
| 200-Day Moving Average | 1.39 USD |
PHIO Share Statistics
| Avg. Volume (3 month) | 166.41K USD |
| Avg. Daily Volume (10-Days) | 191.81K USD |
| Shares Outstanding | 11.62M |
| Float | 11.55M |
| Short Ratio | 2.24 |
| % Held by Insiders | 1.93% |
| % Held by Institutions | 10.82% |
| Shares Short | 313.8K |
| Short % of Float | 2.70% |
| Short % of Shares Outstanding | 2.70% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.65% |
| Return on Equity (ttm) | -76.36% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -6525000 USD |
| EBITDA | -11511500 USD |
| Net Income Avi to Common (ttm) | -10932000 USD |
| Diluted EPS (ttm) | -1.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.03M USD |
| Total Cash Per Share (mrq) | 1.47 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 18.318 |
| Book Value Per Share (mrq) | 1.417 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10707000 USD |
| Levered Free Cash Flow (ttm) | -6979875 USD |
Profile of Phio Pharmaceuticals
| Country | United States |
| State | PA |
| City | King of Prussia |
| Address | 411 Swedeland Road |
| ZIP | 19406 |
| Phone | 610 947 0251 |
| Website | https://phiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Q&A For Phio Pharmaceuticals Stock
What is a current PHIO stock price?
Phio Pharmaceuticals PHIO stock price today per share is 1.04 USD.
How to purchase Phio Pharmaceuticals stock?
You can buy PHIO shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Phio Pharmaceuticals?
The stock symbol or ticker of Phio Pharmaceuticals is PHIO.
Which industry does the Phio Pharmaceuticals company belong to?
The Phio Pharmaceuticals industry is Biotechnology.
How many shares does Phio Pharmaceuticals have in circulation?
The max supply of Phio Pharmaceuticals shares is 11.62M.
What is Phio Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Phio Pharmaceuticals PE Ratio is now.
What was Phio Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Phio Pharmaceuticals EPS is -1.38 USD over the trailing 12 months.
Which sector does the Phio Pharmaceuticals company belong to?
The Phio Pharmaceuticals sector is Healthcare.
Phio Pharmaceuticals PHIO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
146.53 USD — |
-0.75
|
— — | 144.14 USD — | 148.72 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}